RESOLUTION THERAPEUTICS
Updated 75 days ago
Private Limited Company
- Active - 11112568 (CH)
- Age: 7 years
- ID: 53447092/11
5 Little France Drive, Edinburgh, EH16 4UU
• 72110 - Research and experimental development on biotechnology
Resolution Therapeutics is developing macrophage cell therapies to treat diseases characterised by life-threatening inflammatory organ damage. The Company is built upon more than a decade of work in the Founders' laboratories characterising the role of macrophages in organ repair, including the liver, both in the pre-clinical and clinical settings. Resolution will discover, develop, manufacture and take to market macrophage cell therapies based on its proprietary platform of macrophage biology, cell engineering and manufacturing processes... Resolution is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease... Our initial focus is in end-stage liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a..
Also known as: RESOLUTION THERAPEUTICS LIMITED
Previous names: SYNCONA COLLABORATION (E) LIMITED
Registration numbers: 11112568 (CH)